Melqart still owns 767,525 shares of Cytokinetics, worth about $65 million, or $6 of every $100 they have in stocks. Between April and June they sold 76,424 shares (down 9%).
Mar 31
843,949
Jun 30
767,525
The numbers
Shares they own
767,525
Change since Mar 31
−76,424
−9.1%
Shares on Mar 31
843,949
Value on Jun 30, 2026
$65,385,455
about $65 million
Share of their money
6.2%
$6 of every $100 · 5th of 40
Price per share on Jun 30
$85.19
Value of the shares they sold
about $7 million
at the Jun 30 price
Kind
Shares
Also owned by
No other fund we follow
More about Cytokinetics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.